| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
| glp-1 receptor, partial | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 14 | 0 | 0 | 14 |
| SMAD family member 2 | 9 | 0 | 0 | 9 |
| Fumarate hydratase | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 9 | 0 | 0 | 9 |
| TDP1 protein | 17 | 0 | 0 | 17 |
| GLI family zinc finger 3 | 18 | 0 | 0 | 18 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| AR protein | 22 | 0 | 0 | 22 |
| Smad3 | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 12 | 0 | 0 | 12 |
| nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
| progesterone receptor | 17 | 0 | 0 | 17 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
| glucocorticoid receptor [Homo sapiens] | 21 | 0 | 0 | 21 |
| retinoic acid nuclear receptor alpha variant 1 | 18 | 0 | 0 | 18 |
| retinoid X nuclear receptor alpha | 15 | 0 | 0 | 15 |
| estrogen-related nuclear receptor alpha | 16 | 0 | 0 | 16 |
| farnesoid X nuclear receptor | 12 | 0 | 0 | 12 |
| pregnane X nuclear receptor | 16 | 0 | 0 | 16 |
| estrogen nuclear receptor alpha | 21 | 0 | 0 | 21 |
| G | 7 | 0 | 0 | 7 |
| cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
| polyprotein | 3 | 0 | 0 | 3 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 10 | 0 | 0 | 10 |
| peroxisome proliferator activated receptor gamma | 12 | 0 | 0 | 12 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 14 | 0 | 0 | 14 |
| IDH1 | 4 | 0 | 0 | 4 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 15 | 0 | 0 | 15 |
| thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
| activating transcription factor 6 | 6 | 0 | 0 | 6 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 7 | 0 | 0 | 7 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
| Histone H2A.x | 8 | 0 | 0 | 8 |
| Caspase-7 | 3 | 0 | 0 | 3 |
| vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| caspase-3 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform 2 | 17 | 0 | 0 | 17 |
| heat shock protein beta-1 | 7 | 0 | 0 | 7 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 17 | 0 | 0 | 17 |
| nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
| geminin | 15 | 0 | 0 | 15 |
| survival motor neuron protein isoform d | 6 | 0 | 0 | 6 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| lamin isoform A-delta10 | 7 | 0 | 0 | 7 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
| Interferon beta | 9 | 0 | 0 | 9 |
| HLA class I histocompatibility antigen, B alpha chain | 7 | 0 | 0 | 7 |
| Cellular tumor antigen p53 | 11 | 0 | 0 | 11 |
| Glutamate receptor 2 | 9 | 0 | 0 | 9 |
| Alpha-synuclein | 3 | 2 | 0 | 5 |
| Spike glycoprotein | 4 | 0 | 0 | 4 |
| Guanine nucleotide-binding protein G | 4 | 0 | 0 | 4 |
| Inositol hexakisphosphate kinase 1 | 7 | 0 | 0 | 7 |
| cytochrome P450 2C9, partial | 7 | 0 | 0 | 7 |
| acetylcholinesterase | 3 | 0 | 0 | 3 |
| pregnane X receptor | 6 | 0 | 0 | 6 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
| chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| Glucocorticoid receptor | 0 | 17 | 2 | 20 |
| Sex hormone-binding globulin | 0 | 1 | 12 | 13 |
| Glycine receptor subunit alpha-1 | 0 | 16 | 0 | 16 |
| Corticosteroid-binding globulin | 0 | 8 | 0 | 8 |
| Adenosine receptor A3 | 0 | 4 | 0 | 4 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 15 | 1 | 16 |
| Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
| Glycine receptor subunit beta | 0 | 16 | 0 | 16 |
| Glycine receptor subunit alpha-2 | 0 | 16 | 0 | 16 |
| Glycine receptor subunit alpha-3 | 0 | 16 | 0 | 16 |
| Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 4 | 0 | 4 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| TAR DNA-binding protein 43 | 6 | 0 | 0 | 6 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| Mineralocorticoid receptor | 0 | 3 | 2 | 5 |
| Mineralocorticoid receptor | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
| ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
| Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 7 |
| Bile salt export pump | 0 | 11 | 0 | 11 |
| Aromatase | 0 | 5 | 0 | 8 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
| Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
| interleukin 8 | 5 | 0 | 0 | 5 |
| aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
| peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
| muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
| Beta-glucuronidase | 0 | 2 | 0 | 2 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 0 | 0 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 8 | 0 | 0 | 8 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
| P53 | 1 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 5 | 0 | 0 | 5 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 0 | 0 | 5 |
| GABA theta subunit | 5 | 0 | 0 | 5 |
| ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
| Ataxin-2 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | 5 | 0 | 0 | 5 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| GLS protein | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 3 | 0 | 3 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 2 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
| Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| Plasma kallikrein | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 5 | 4 | 9 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 4 | 4 | 10 |
| Androgen receptor | 0 | 1 | 2 | 3 |
| Angiotensin-converting enzyme | 0 | 0 | 1 | 1 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
| Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
| ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
| prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
| Prostacyclin receptor | 0 | 2 | 1 | 3 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 7 | 2 | 9 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
| Luciferase | 3 | 0 | 0 | 3 |
| USP1 protein, partial | 2 | 0 | 0 | 2 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| Vpr | 1 | 0 | 0 | 1 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
| Aldehyde oxidase | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 2 | 2 | 4 |
| GALC protein | 1 | 0 | 0 | 1 |
| Gonadotropin-releasing hormone receptor | 0 | 1 | 0 | 1 |
| Gonadotropin-releasing hormone receptor | 0 | 2 | 0 | 2 |
| Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
| Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
| Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |